跳至主要内容
临床试验/NCT01233518
NCT01233518已完成不适用

Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

HeartFlow, Inc.1 个研究点 分布在 1 个国家目标入组 285 人开始时间: 2010年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
285
试验地点
1
主要终点
Percentage of Participants With Diagnostic Accuracy of CCTA Plus FFRCT and CCTA Alone

研究概览

简要总结

This is a prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic significance of coronary lesions, as compared to direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard.

详细描述

285 patient, prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic significance of coronary lesions, as compared to direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age >18 years
  • •Patients providing written informed consent
  • •Scheduled to undergo clinically-indicated non-emergent invasive coronary angiography (ICA)
  • •Has undergone >64 multidetector row CCTA within 60 days prior to ICA
  • •No cardiac interventional therapy between the CCTA and ICA

排除标准

  • •Prior coronary artery bypass graft (CABG) surgery
  • •Prior percutaneous coronary intervention (PCI) for which suspected coronary artery lesion(s) are within a stented coronary vessel
  • •Contraindication to adenosine, including 2nd or 3rd degree heart block; sick sinus syndrome; long QT syndrome; severe hypotension, severe asthma, , severe COPD or bronchodilator-dependent COPD
  • •Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
  • •Recent prior myocardial infarction within 40 days of ICA
  • •Known complex congenital heart disease
  • •Prior pacemaker or internal defibrillator lead implantation
  • •Prosthetic heart valve
  • •Significant arrhythmia or tachycardia
  • •Impaired chronic renal function (serum creatinine >1.5 mg/dl
  • •Patients with known anaphylactic allergy to iodinated contrast
  • •Pregnancy or unknown pregnancy status
  • •Body mass index >35
  • •Patient requires an emergent procedure
  • •Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema
  • •Any active, serious, life-threatening disease with a life expectancy of less than 2 months
  • •Inability to comply with study procedures

研究组 & 干预措施

Single arm study

Other

Patients will receive cCTA, ICA, FFR, and cFFR per protocol.

干预措施: FFR (Device)

结局指标

主要结局

Percentage of Participants With Diagnostic Accuracy of CCTA Plus FFRCT and CCTA Alone

时间窗: 1 day

Diagnostic accuracy of CCTA (Cardiac Computed Tomography Angiography) plus FFRCT (Noninvasive Fractional Flow Reserve computed from CCTA) to determine presence or absence of at least one hemodynamically (HD)-significant coronary artery stenosis\* at the subject level using binary outcomes when compared to invasive FFR (Fractional Flow Reserve) as the reference standard. In the per-patient analysis, vessels with the most adverse clinical status were selected to represent a given patient. FFR and FFRCT measurements were recorded on a continuous scale and dichotomized at the 0.80 threshold (values ≤0.80 considered diseased; values \>0.80 nondiagnostic for ischemia). Stenosis on CCTA was recorded at the 50% threshold (stenoses ≥50% considered obstructive and \<50% as non-significant). Prespecified primary endpoint was expected to be greater than 70% of the lower bound of the 95% confidence interval.

次要结局

  • Diagnostic Performance of CCTA Plus FFRCT at the Subject Level(1 day)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验